Crossmark

Reply to “Reappraisal of the MASLD predictive factors: insights beyond the surface”

Published Online: 2026-04-15

Authors

Tsutsumi, Tsubasa https://orcid.org/0000-0001-6571-9874
Kawaguchi, Takumi

Fujii, Hideki
License Information

Text and Data Mining valid from 2026-04-15

Version of Record valid from 2026-04-15
More Information

Article History

Received: 25 March 2026

Accepted: 9 April 2026

First Online: 15 April 2026

Declarations

:

: T.T. provided a consultant to Madrigal. T.K. received lecture fees from Janssen Pharmaceutical K.K., Taisho Pharmaceutical Co., Ltd., Kowa Company, Ltd., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., ASKA Pharmaceutical Co., Ltd., AbbVie GK., EA Pharma Co., Ltd.

Document is current